Rigel Pharmaceuticals
A Senior Director, Good Clinical Practices (GCP) at Rigel Pharmaceuticals leads the design and implementation of a global GCP quality framework, ensuring compliance with regulatory requirements and fostering a proactive quality culture across clinical development.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
1996
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company markets approved products including TAVALISSE, REZLIDHIA, and Gavreto, and maintains a pipeline of clinical programs including IRAK1/4 and RIPK1 inhibitors. Rigel is publicly traded under the ticker RIGL and is headquartered in South San Francisco, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rigel Pharmaceuticals.
46% above the average for this role
Senior Manager, Quality Assurance GCP
Crinetics Pharmaceuticals
Sr Manager, GCP Quality Assurance
Sun Pharmaceutical Industries Limited
Executive Director, GCP Quality Assurance
Aurabiosciences
Senior Manager, GCP Auditor
lifelancer
Associate Director, GCP QA
Mirum Pharmaceuticals
Director, GCP Quality Assurance
Acadia Pharmaceuticals Inc.